CD79B and B-cell non-Hodgkin lymphoma: We found that LBCLs exhibited lower and heterogeneous CD79b expression, with 18% of cases showing almost exclusively intracellular positivity and, in particular, low surface expression in primary mediastinal B-cell lymphomas.